Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The TJX Companies, Inc. (TJX): Is J.C. Penney Company, Inc. (JCP)’s Rally Legit?

The Foolish bottom line

J.C. Penney Company, Inc. (NYSE:JCP) has a new CEO, billions in new cash, and counts one of the world’s most famous investors among its backers. However, deep fundamental problems surrounding the company still exist. While investors should celebrate the recent stock price rally, it remains to be seen whether these new funds can translate into renewed profitability.

J.C. Penney no longer pays a dividend, whereas TJX is firing on all cylinders. The TJX Companies, Inc. (NYSE:TJX) recently reported gangbusters growth in sales and profits, increased its common stock dividend, and is using some of its solid cash generation to buy back shares. Investors don’t need to gamble on whether J.C. Penney Company, Inc. (NYSE:JCP) can turn itself around: there are other profitable clothing retailers, like The TJX Companies, Inc. (NYSE:TJX), that should be on your watch list instead.

The article Is J.C. Penney’s Rally For Real? originally appeared on Fool.com and is written by Robert Ciura.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!